BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37105017)

  • 1. Use of risk-based cervical screening programs in resource-limited settings.
    Perkins RB; Smith DL; Jeronimo J; Campos NG; Gage JC; Hansen N; Rodriguez AC; Cheung LC; Egemen D; Befano B; Novetsky AP; Martins S; Kalpathy-Cramer J; Inturrisi F; Ahmed SR; Marcus J; Wentzensen N; de Sanjose S; Schiffman M
    Cancer Epidemiol; 2023 Jun; 84():102369. PubMed ID: 37105017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative assessment of test characteristics of cervical cancer screening methods for implementation in low-resource settings.
    Asgary R; Beideck E; Naderi R
    Prev Med; 2022 Jan; 154():106883. PubMed ID: 34785209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study of cervical cancer screening algorithms].
    Zhao FH; Zhang WH; Pan QJ; Zhang X; Chen W; Liu B; Ma JF; Hu SY; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):420-4. PubMed ID: 20819481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of "automated visual evaluation" for cervical cancer screening: The promise and challenges in adapting deep-learning for clinical testing: Interdisciplinary principles of automated visual evaluation in cervical screening.
    Desai KT; Befano B; Xue Z; Kelly H; Campos NG; Egemen D; Gage JC; Rodriguez AC; Sahasrabuddhe V; Levitz D; Pearlman P; Jeronimo J; Antani S; Schiffman M; de Sanjosé S
    Int J Cancer; 2022 Mar; 150(5):741-752. PubMed ID: 34800038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening in a low-resource setting: a pilot study on an HPV-based screen-and-treat approach.
    Kunckler M; Schumacher F; Kenfack B; Catarino R; Viviano M; Tincho E; Tebeu PM; Temogne L; Vassilakos P; Petignat P
    Cancer Med; 2017 Jul; 6(7):1752-1761. PubMed ID: 28580596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triage of HPV positive women in cervical cancer screening.
    Wentzensen N; Schiffman M; Palmer T; Arbyn M
    J Clin Virol; 2016 Mar; 76 Suppl 1(Suppl 1):S49-S55. PubMed ID: 26643050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing high risk HPV-based primary screening for cervical cancer in low- and middle-income countries: opportunities and challenges.
    Pimple SA; Mishra GA
    Minerva Ginecol; 2019 Oct; 71(5):365-371. PubMed ID: 31698891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis.
    Campos NG; Tsu V; Jeronimo J; Regan C; Resch S; Clark A; Sy S; Kim JJ
    Int J Cancer; 2019 Feb; 144(4):687-696. PubMed ID: 30132850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi.
    Cubie HA; Campbell C
    Womens Health (Lond); 2020; 16():1745506520914804. PubMed ID: 32364058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of modifications to a human papillomavirus assay to optimise its utility for cervical cancer screening in low-resource settings: a diagnostic accuracy study.
    Kuhn L; Saidu R; Boa R; Tergas A; Moodley J; Persing D; Campbell S; Tsai WY; Wright TC; Denny L
    Lancet Glob Health; 2020 Feb; 8(2):e296-e304. PubMed ID: 31981559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating feasibility of 2021 WHO protocol for cervical cancer screening in underscreened populations: PREvention and SCReening Innovation Project Toward Elimination of Cervical Cancer (PRESCRIP-TEC).
    Sultanov M; Zeeuw J; Koot J; der Schans JV; Beltman JJ; Fouw M; Majdan M; Rusnak M; Nazrul N; Rahman A; Nakisige C; Rao AP; Prasad K; Guruvare S; Biesma R; Versluis M; de Bock GH; Stekelenburg J
    BMC Public Health; 2022 Jul; 22(1):1356. PubMed ID: 35840949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus testing in cervical cancer screening.
    Castle PE; Cremer M
    Obstet Gynecol Clin North Am; 2013 Jun; 40(2):377-90. PubMed ID: 23732037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
    Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
    Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary HPV screening for cervical cancer.
    Bhatla N; Singhal S
    Best Pract Res Clin Obstet Gynaecol; 2020 May; 65():98-108. PubMed ID: 32291178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial.
    Denny L; Kuhn L; De Souza M; Pollack AE; Dupree W; Wright TC
    JAMA; 2005 Nov; 294(17):2173-81. PubMed ID: 16264158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening.
    Snijders PJ; Verhoef VM; Arbyn M; Ogilvie G; Minozzi S; Banzi R; van Kemenade FJ; Heideman DA; Meijer CJ
    Int J Cancer; 2013 May; 132(10):2223-36. PubMed ID: 22907569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.
    Aoyama-Kikawa S; Fujita H; Hanley SJB; Kasamo M; Kikuchi K; Torigoe T; Matsuno Y; Tamakoshi A; Sasaki T; Matsuura M; Kato Y; Dong P; Watari H; Saito T; Sengoku K; Sakuragi N
    Cancer Sci; 2018 Jun; 109(6):2003-2012. PubMed ID: 29660849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A direct comparison of four high-risk human papillomavirus tests versus the cobas test: Detecting CIN2+ in low-resource settings.
    Xue P; Gao LL; Yin J; Han LL; Zhao J; Li L; Seery S; Han XY; Li TY; Jiang Y; Chen W; Shen J
    J Med Virol; 2019 Jul; 91(7):1342-1350. PubMed ID: 30854653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C; Sargent A; Kitchener HC; Peto J
    Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.